MTST : Summary for METASTAT INC - Yahoo Finance

U.S. Markets closed

MetaStat, Inc. (MTST)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.45-0.15 (-9.38%)
At close: 2:52PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.60
Bid0.00 x
Ask0.00 x
Day's Range1.45 - 1.60
52 Week Range1.15 - 3.45
Avg. Volume5,160
Market Cap6.83M
PE Ratio (TTM)-0.41
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire14 days ago

    MetaStat to Present at the 19th Annual BIO CEO & Investor Conference

    MetaStat, Inc. , a pre-commercial biotechnology company, today announced that Douglas A. Hamilton, President and Chief Executive Officer, is scheduled to present at the 19th Annual BIO CEO & Investor Conference in New York City.

  • Business Wirelast month

    MetaStat, Inc. to Present at Biotech Showcase™ 2017

    MetaStat, Inc. , a pre-commercial biotechnology company focused on the development and commercialization of diagnostic tests that are prognostic for risk of cancer metastasis, companion diagnostics to predict drug response, and anti-metastatic drugs, announced today that the Company will be presenting at the 9th Annual Biotech Showcase™ conference held in San Francisco from January 9th -11th at the ...

  • Business Wire2 months ago

    MetaStat Receives Additional State Clinical Laboratory Licenses

    MetaStat, Inc. , a pre-commercial biotechnology company, today announced it has received California, Florida, Pennsylvania, and Rhode Island state licensure for its next-generation digital pathology laboratory in Boston, Massachusetts.